Clinical Trial Update: A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for liposome-entrapped mitoxantrone hydrochloride injection in relapsed/refractory peripheral T-cell lymphoma and NK/T-cell lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nk T-cell Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• liposome-entrapped mitoxantrone hydrochloride injection (mitoxantrone hydrochloride liposome-entrapped)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Relapsed or Refractory Peripheral T-cell and NK/T-cell Lymphoma | Phase 2 | Status: UNKNOWN